Aurora's research in auto-flowering technology and the acquisition of a US patent could enhance its competitive edge in cannabis cultivation, especially in high-latitude regions. The launch of a new CBD lozenge in collaboration with Vectura Fertin Pharma could also expand its product offerings and market reach. Despite a recent drop in share price, these innovations may positively impact Aurora's stock in the short term.